PCDH17 gene promoter methylation status in a cohort of Egyptian women with epithelial ovarian cancer
Abstract Background and objective Ovarian cancer is a leading cause of female mortality. Epigenetic changes occur in early stages of carcinogenesis and represent a marker for cancer diagnosis. Protocadherin 17 (PCDH17) is a tumor suppressor gene involved in cell adhesion and apoptosis. The methylati...
Main Authors: | Sherif Mohamed Elsharkawi, Dalal Elkaffash, Pacint Moez, Nour El-Etreby, Eman Sheta, Raghda Saad Zaghloul Taleb |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-01-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-023-10549-3 |
Similar Items
-
Genetic variants and phenotype analysis in a five-generation Chinese pedigree with PCDH19 female-limited epilepsy
by: Wenjuan Zhou, et al.
Published: (2023-03-01) -
High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma
by: Maria Cristina Curia, et al.
Published: (2019-05-01) -
Mapping the Interface between New World Hantaviruses and Their Receptor, PCDH1
by: Megan M. Slough, et al.
Published: (2020-06-01) -
Novel and de novo mutation of PCDH19 in Girls Clustering Epilepsy
by: Li Yang, et al.
Published: (2019-12-01) -
Protocadherin 17 is a tumor suppressor and is frequently methylated in nasopharyngeal carcinoma
by: He Y, et al.
Published: (2019-02-01)